Lebel E, Abdulgawad A, Bramanti S, Garate G, Ho P, Keränen M, Cohen Y, Vase M, Khot A, Kristensen I, Leblanc R, Lee C, Legiec W, Magen H, Mateos M, Oh D, Pour L, Schutz N, Spyridonidis A, Weisel K, Zaucha J, Larson S, Varshavsky-Yanovsky A, Grazioli K, Basudhar D, Hu H, Meng Y, Eldjerou L, Bal S, Harrison S, Popat R, Raab M, Rodriguez-Otero P. P58 | TRIAL IN PROGRESS: QUINTESSENTIAL-2 – A PHASE 3 STUDY OF ARLOCABTAGENE AUTOLEUCEL VS. STANDARD OF CARE IN ADULT PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA EXPOSED TO LENALIDOMIDE. haematol [Internet]. 2026Apr.15 [cited 2026Sep.26];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14111